Establishment Labs Holdings (ESTA) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.77% |
| Dec 31, 2025 | 30.00% |
| Sep 30, 2025 | 56.46% |
| Jun 30, 2025 | 5.13% |
| Mar 31, 2025 | 16.35% |
| Dec 31, 2024 | -123.65% |
| Sep 30, 2024 | 23.52% |
| Jun 30, 2024 | -20.46% |
| Mar 31, 2024 | -11.71% |
| Dec 31, 2023 | 72.30% |
| Sep 30, 2023 | -43.85% |
| Jun 30, 2023 | -14.67% |
| Mar 31, 2023 | -61.52% |
| Dec 31, 2022 | -199.56% |
| Sep 30, 2022 | 81.65% |
| Jun 30, 2022 | -387.74% |
| Mar 31, 2022 | 28.62% |
| Dec 31, 2021 | 47.76% |
| Sep 30, 2021 | -2,153.65% |
| Jun 30, 2021 | 89.98% |
| Mar 31, 2021 | -293.33% |
| Dec 31, 2020 | 171.33% |
| Sep 30, 2020 | 19.43% |
| Jun 30, 2020 | 16.26% |
| Mar 31, 2020 | -735.78% |
| Dec 31, 2019 | 109.73% |
| Sep 30, 2019 | -3.35% |
| Jun 30, 2019 | -29.68% |
| Mar 31, 2019 | -1.53% |
| Dec 31, 2018 | 16.50% |
| Sep 30, 2018 | -11.97% |
| Jun 30, 2018 | -37.32% |
| Mar 31, 2018 | 12.98% |
| Dec 31, 2017 | 18.59% |